BLISS GVS PHARMA LTD. - 506197 - Clarification On Price Movement
Kindly refer the attachment.01-04-2021
01-04-2021
BLISS GVS PHARMA LTD. - 506197 - Closure of Trading Window
This is to inform you that pursuant to Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited ('the Company') will remain closed for Insiders, Designated Persons and their immediate relatives of the Company with effect from Thursday, April 01, 2021 until 48 hours after the announcement of the audited financial results of the Company for the quarter and year ended March 31, 2021.31-03-2021
BLISS GVS PHARMA LTD. - 506197 - Commercial Suit For Infringement Of Intellectual Property Rights
As per the attachment.26-03-2021
BLISS GVS PHARMA LTD. - 506197 - Regarding Clarification On Price Movement
We refer to your letter dated March 18, 2021, seeking clarification on price movement in the shares of Bliss GVS Pharma Limited (the 'Company'). We wish to inform you that as on date, there is no material relevant information /event (including impending announcement) having a bearing on the operations/performance including price/volume of the Company which requires disclosure as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ("Listing Regulations"). All the information/events which have a bearing on the operations of the Company are disclosed to the Exchange on immediate basis as per Regulation 30 of the Listing Regulations. The Company has always abided by and complied with all regulatory requirements and will continue to do so. We further request you to take note that since the shares of the Company are freely traded on the Stock Exchange; the Company is unable to comment on the movement in share price of the Company.18-03-2021
BLISS GVS PHARMA LTD. - 506197 - Clarification sought from Bliss GVS Pharma Ltd
The Exchange has sought clarification from Bliss GVS Pharma Ltd on March 18, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.18-03-2021
BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the following shareholder:26-02-2021
BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Please find enclosed herewith the reports related to the violation of Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons of Bliss GVS Pharma Limited ('PIT CODE) by two Designated Persons, in the format prescribed by SEBI Circular SEBI/HO/ISD/ISD/CIR/P/2020/135 dated July 23, 2020.05-02-2021
BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement of unaudited financial results of the Company for the quarter and nine months ended December 31, 2020 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on January 23, 2021.25-01-2021
BLISS GVS PHARMA LTD. - 506197 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
This is with reference to the Board Meeting of the Company which was held yesterday i.e. Thursday, January 21, 2021, the Board has considered and approved the 'Commencement of construction of Phase II of new manufacturing unit for Oral Solid Dosage Facility at Palghar East in Maharashtra' In relation to above, the Company is further extending its period of closure of trading window which is already closed w.e.f. January 01, 2021 in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading Window for dealing in securities/shares of Bliss GVS Pharma Limited ('the Company') shall continue to remain closed for all the Designated Persons and their immediate relatives of the Company till February 01, 2021. Trading Window will be open from February 02, 2021.22-01-2021
BLISS GVS PHARMA LTD. - 506197 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Intimation Regarding Continuation Of Closure Of Trading Window Of The Company
This is with reference to the Board Meeting of the Company which was held yesterday i.e. Thursday, January 21, 2021, the Board has considered and approved the 'Commencement of construction of Phase II of new manufacturing unit for Oral Solid Dosage Facility at Palghar East in Maharashtra'. In relation to above, the Company is further extending its period of closure of trading window which is already closed w.e.f. January 01, 2021 in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading Window for dealing in securities/shares of Bliss GVS Pharma Limited ('the Company') shall continue to remain closed for all the Designated Persons and their immediate relatives of the Company till February 01, 2021. Trading Window will be open from February 02, 2021.22-01-2021